Manabu Ato

Manabu Ato

Auto-generated profile, based on publicly available information

Manabu Ato

Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Emerging Infectious Diseases
Verified
Journal Article
Open access
HNHo Namkoong
Ho Namkoong
AKAtsuyuki Kurashima
Atsuyuki Kurashima
KMKozo Morimoto
Kozo Morimoto
YHYoshihiko Hoshino
Yoshihiko Hoshino
NHNaoki Hasegawa
Naoki Hasegawa
SMSatoshi Mitarai
Satoshi Mitarai

30 January 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TOTaishi Onodera
Taishi Onodera
YTYoshimasa Takahashi
Yoshimasa Takahashi
YYYusuke Yokoi
Yusuke Yokoi
MAManabu Ato
Manabu Ato
YKYuichi Kodama
Yuichi Kodama
KKKazuo Kobayashi
Kazuo Kobayashi
After pulmonary virus infection, virus-binding B cells ectopically accumulate in the lung. However, their contribution to protective immunity against reinfecting viruses remains unknown. Here, we show the phenotypes and protective functions of virus-binding memory B cells that persist in the lung following pulmonary infection with influenza virus. A fraction of virus-binding B-cell population in the lung expressed surface markers for splenic mature memory B cells (CD73, CD80, and CD273) along with CD69 and CXCR3 that are up-regulated on lung effector/memory T cells. The lung B-cell population with memory phenotype persisted for more than 5 mo after infection, and on reinfection promptly differentiated into plasma cells that produced virus-neutralizing antibodies locally. This production of local IgG and IgA neutralizing antibody was correlated with reduced virus spread in adapted hosts. Our data demonstrates that infected lungs harbor a memory B-cell subset with distinctive phenotype and ability to provide protection against pulmonary virus reinfection.

10 September 2004 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
PKPaul M. Kaye
Paul M. Kaye
MSMattias Svensson
Mattias Svensson
MAManabu Ato
Manabu Ato
AMAsher Maroof
Asher Maroof
RPRosalind Polley
Rosalind Polley
CEChristian R. Engwerda
Christian R. Engwerda

31 August 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YAYu Adachi
Yu Adachi
TOTaishi Onodera
Taishi Onodera
YYYuki Yamada
Yuki Yamada
RDRina Daio
Rina Daio
MTMakoto Tsuiji
Makoto Tsuiji
YTYoshimasa Takahashi
Yoshimasa Takahashi
Respiratory influenza virus infection induces cross-reactive memory B cells targeting invariant regions of viral escape mutants. However, cellular events dictating the cross-reactive memory B cell responses remain to be fully defined. Here, we demonstrated that lung-resident memory compartments at the site of infection, rather than those in secondary lymphoid organs, harbor elevated frequencies of cross-reactive B cells that mediate neutralizing antibody responses to viral escape. The elevated cross-reactivity in the lung memory compartments was correlated with high numbers of VH mutations and was dependent on a developmental pathway involving persistent germinal center (GC) responses. The persistent GC responses were focused in the infected lungs in association with prolonged persistence of the viral antigens. Moreover, the persistent lung GCs supported the exaggerated B cell proliferation and clonal selection for cross-reactive repertoires, which served as the predominant sites for the generation of cross-reactive memory progenitors. Thus, we identified the distinct GC selection at local sites as a key cellular event for cross-reactive memory B cell response to viral escape, a finding with important implications for developing broadly protective influenza vaccines.

1 April 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
TITadayoshi Ikebe
Tadayoshi Ikebe
MAManabu Ato
Manabu Ato
TMTakayuki Matsumura
Takayuki Matsumura
HHHideki Hasegawa
Hideki Hasegawa
TSTetsutaro Sata
Tetsutaro Sata
HWHaruo Watanabe
Haruo Watanabe
Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock and multiorgan failure; it has a high mortality rate. Although a number of studies have attempted to determine the crucial factors behind the onset of STSS, the responsible genes in group A Streptococcus have not been clarified. We previously reported that mutations of csrS/csrR genes, a two-component negative regulator system for multiple virulence genes of Streptococcus pyogenes, are found among the isolates from STSS patients. In the present study, mutations of another negative regulator, rgg, were also found in clinical isolates of STSS patients. The rgg mutants from STSS clinical isolates enhanced lethality and impaired various organs in the mouse models, similar to the csrS mutants, and precluded their being killed by human neutrophils, mainly due to an overproduction of SLO. When we assessed the mutation frequency of csrS, csrR, and rgg genes among S. pyogenes isolates from STSS (164 isolates) and non-invasive infections (59 isolates), 57.3% of the STSS isolates had mutations of one or more genes among three genes, while isolates from patients with non-invasive disease had significantly fewer mutations in these genes (1.7%). The results of the present study suggest that mutations in the negative regulators csrS/csrR and rgg of S. pyogenes are crucial factors in the pathogenesis of STSS, as they lead to the overproduction of multiple virulence factors. Group A streptococcus (GAS) causes life-threatening severe invasive diseases, including necrotizing fasciitis and streptococcal toxic shock-like syndrome. Although many studies have attempted to determine factors that are crucial for the onset of streptococcal toxic shock syndrome (STSS), bacterial factors responsible for it have not been clarified. By comparing genome sequences of clinical GAS isolates from STSS with those of non-invasive infections, we showed that mutations of negative regulator genes (csrS, csrR, rgg) were detected at a high frequency of more than 50% in STSS isolates, but at a low frequency of less than 2% in non-invasive isolates. These mutations of negative regulators were found in various emm-genotyped STSS isolates but not in a particular emm genotype. These mutants enhanced virulence in mouse models. Such results indicated that mutations of bacterial negative regulators are crucial for the pathogenesis of STSS due to the overproduction of multiple virulence factors under the de-repressed conditions.

1 November 2004 in Trends in Parasitology
Verified
Journal Article
Closed access
CEChristian R. Engwerda
Christian R. Engwerda
MAManabu Ato
Manabu Ato
PKPaul M. Kaye
Paul M. Kaye